Liquidia
开盘价
市值
最高价
最低价
收盘价
成交量
市盈率
股息率
Liquidia简介
Liquidia Technologies，Inc.是一家临床生物制药公司，专注于人类疗法的开发和商业化，使用其专有的打印技术来改变患者的生活。它分为两个部门：医药产品和合作与许可。其产品线中的两个候选产品：用于治疗肺动脉高压的LIQ861和用于治疗局部术后疼痛的LIQ865。Liqudia Technologies由约瑟夫·M·德西蒙、阿肖克·K·门迪拉塔、爱德华·T·萨穆尔斯基、威廉·R·凯南、金格·丹尼森和杰森·罗兰于2004年创立，总部设在北卡罗来纳州莫里斯维尔。
如何购买 Liquidia (LQDA)
登录
1分钟开户
仅需1分钟即可完成账户申请和验证。整个过程完全自助，支持 RockFlow App 和网页端操作。
充值资金
账户验证完成后，您可以使用首选的支付方式向账户充值。
购买 LQDA
通过 RockFlow App 或网页端搜索 LQDA，输入您想要投资的金额，然后点击确认即可完成交易。
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.